Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer

Prostate-specific membrane antigen (PSMA) represents a promising target for PSMA-overexpressing diseases, especially prostate cancer-a common type of cancer among men worldwide. In response to the challenges in tackling prostate cancers, several promising PSMA inhibitors from a variety of molecular...

Descripción completa

Detalles Bibliográficos

Autores principales:	Rien Ritawidya, Hendris Wongso, Nurmaya Effendi, Anung Pujiyanto, Wening Lestari, Herlan Setiawan, Titis Sekar Humani
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Tabriz University of Medical Sciences 2023-11-01
Colección:	Advanced Pharmaceutical Bulletin
Materias:	prostate cancer metastatic-castration resistant prostate cancer lutetium-177 psma-617 radioligand
Acceso en línea:	https://apb.tbzmed.ac.ir/PDF/apb-13-701.pdf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!